Maternal obesity-induced endoplasmic reticulum stress causes metabolic alterations and abnormal hypothalamic

Soyoung Park1, Alice Jang1, Sebastien G Bouret2,3

  • 1The Saban Research Institute, Developmental Neuroscience Program, Children's Hospital Los Angeles, Los Angeles, California, United States of America.

Plos Biology
|March 13, 2020
PubMed

Insights

Maternal obesity in mice programs offspring for metabolic disease via endoplasmic reticulum (ER) stress. Early life ER stress intervention reversed these deficits, highlighting a critical developmental window for preventing obesity and type 2 diabetes.

Area of Science:

  • Metabolic disease
  • Developmental biology
  • Endocrinology

Background:

  • Rising rates of childhood obesity and type 2 diabetes mellitus present a significant public health challenge.
  • Maternal obesity is a key risk factor for metabolic dysfunction in offspring.
  • Endoplasmic reticulum (ER) stress is implicated in leptin resistance and type 2 diabetes.

Purpose of the Study:

  • To investigate the role of early life ER stress in the developmental programming of metabolic disease in offspring from obese mothers.
  • To examine the impact of maternal obesity on offspring metabolic parameters and neurodevelopmental pathways.

Main Methods:

  • Utilized a mouse model of maternal obesity.
  • Assessed offspring for glucose intolerance, body weight, adiposity, and food intake.
  • Analyzed hypothalamic melanocortin circuits and ER stress-related gene expression.
  • Investigated the therapeutic effect of tauroursodeoxycholic acid (TUDCA) on metabolic and neurodevelopmental deficits.

Main Results:

  • Offspring of obese dams exhibited glucose intolerance, increased body weight, adiposity, and food intake.
  • Maternal obesity led to disrupted melanocortin circuits, neonatal hyperleptinemia, and leptin resistance.
  • ER stress markers were elevated in the hypothalamus of neonates from obese mothers.
  • Neonatal TUDCA treatment ameliorated metabolic and neurodevelopmental issues and reversed leptin resistance.

Conclusions:

  • Early life endoplasmic reticulum stress, induced by maternal obesity, contributes to the developmental programming of metabolic disease in offspring.
  • Targeting ER stress during the neonatal period offers a potential therapeutic strategy to prevent or reverse obesity and type 2 diabetes-related complications.
  • Intervention with ER stress-relieving agents like TUDCA can improve metabolic health and neurodevelopmental outcomes in offspring exposed to maternal obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
635
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
7.6K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.6K